Veteran investor and operating executive with experience in private equity, M&A and corporate strategy across healthcare and business services. Steven Albrecht leads deal sourcing, operational improvement and portfolio company governance with a focus on EBITDA expansion and revenue growth initiatives. Prior roles span buyouts, corporate development and board service; education combines finance and management training. Market profile: active in mid‑market control and growth equity transactions.
Veteran investor and operating executive with experience in private equity, M&A and corporate strategy across healthcare and business services. Steven Albrecht leads deal sourcing, operational improvement and portfolio company governance with a focus on EBITDA expansion and revenue growth initiatives. Prior roles span buyouts, corporate development and board service; education combines finance and management training. Market profile: active in mid‑market control and growth equity transactions.
Focuses on control and growth equity in healthcare and business services, targeting mid‑market companies where operational levers can accelerate EBITDA and revenue. Employs a value‑creation approach that pairs disciplined buyout underwriting with hands‑on portfolio governance, prioritizing recurring revenue, margin expansion and scalable commercial initiatives. Capital allocation favors majority or substantial minority stakes with multi‑year horizons, staged capital deployment tied to operational milestones, and conservative leverage. Decision‑making blends quantitative cash‑flow analysis with operational KPIs and executive alignment to de‑risk exits.
Focuses on control and growth equity in healthcare and business services, targeting mid‑market companies where operational levers can accelerate EBITDA and revenue. Employs a value‑creation approach that pairs disciplined buyout underwriting with hands‑on portfolio governance, prioritizing recurring revenue, margin expansion and scalable commercial initiatives. Capital allocation favors majority or substantial minority stakes with multi‑year horizons, staged capital deployment tied to operational milestones, and conservative leverage. Decision‑making blends quantitative cash‑flow analysis with operational KPIs and executive alignment to de‑risk exits.
| Trades 691 | Longs Won 469/691 67% | Profit Factor 12.74 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $220,217.99 |
| Average Win $81,042.52 | Best Trade (Jul 13) $4.44M | Sharpe Ratio -10.03 |
| Average Loss -$13,436.99 | Worst Trade (Sep 30) -$606,939.63 | Z-Score 11.97 (100%) |
| Commissions $0 | Avg. Trade Length 10m 3w | Expectancy $50,688.75 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 9,434 | 8,491 | 7,547 | 6,604 | 5,660 | 4,717 | 3,774 | 2,830 | 1,887 | 943 |